AI in drug discovery

Digital

pharmaphorum podcast Episode 242, Yann Gaston-Mathe, Iktos

JPM2026: Broadening AI drug discovery to include the lab, wi...

Yann Gaston-Mathe, founder and CEO of Iktos, discusses AI drug discovery's shift to real-world operations that are able to incorporate wet lab data.

News

Sarah Skerrat, Isomorphic's chief research officer

J&J bets on Isomorphic for AI-powered drug hunt

Isomorphic Labs has added Johnson & Johnson to the roster of pharma companies tapping into its AI-based drug discovery engine.

News

EMA and FDA agree 'principles' for AI in drug development

The FDA and EMA have come up with guiding principles that they say will underpin future guidance on the use of AI technologies in drug development.

News

Now Iktos teams up with Pierre Fabre in oncology

As Servier announces its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has revealed an integrated collaboration with Iktos

News

Iktos' Chemspeed robotics-powered chemistry platform

Servier signs €1bn-plus AI pact with Iktos

In its second AI-focused drug discovery deal in the space of a week, Servier has announced a €1bn partnership with France's Iktos.

News

Insilico Medicine and Servier logos on a black background

Insilico adds Servier to partnership roster with $888m deal

Insilico has added to its partnerships list with an $888m cancer-focused alliance with Servier, just days after completing its long-awaited IPO.

JPM2026: Broadening AI drug discovery to include the lab, wi...

J&J bets on Isomorphic for AI-powered drug hunt

EMA and FDA agree 'principles' for AI in drug development

Now Iktos teams up with Pierre Fabre in oncology

Servier signs €1bn-plus AI pact with Iktos

Insilico adds Servier to partnership roster with $888m deal

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

AI in drug discovery

Editor's Picks